Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase I/II and Pharmacokinetic Study of 96-Hour Infusional Topotecan and Paclitaxel Chemotherapy for Recurrent Müllerian Tumors

Arlan Fuller, Richard Penson, Jeffrey Supko, Ursula Matulonis, Ross Berkowitz, Annekatherine Goodman, Susana Campos, Kimberly MacNeill, Karen Borden, Sarah Cook, Steven Skates, Michael Seiden. A Phase I/II and Pharmacokinetic Study of 96-Hour Infusional Topotecan and Paclitaxel Chemotherapy for Recurrent Müllerian Tumors. Proc Am Soc Clin Oncol. 2000; 19(abstr 1552).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.